Rami Abazid | Clinical Trials | Research Excellence Award

Published on by Top Pharmaceutical

Dr. Rami Abazid | Clinical Trials | Research Excellence Award

Northern Ontario School of Medicine University | Canada

Dr. Rami Abazid is a distinguished cardiologist and academic leader recognized for his extensive expertise in advanced cardiovascular imaging and his long-standing contributions to clinical cardiology. He currently serves as an Assistant Professor at the Northern Ontario School of Medicine University and practices as a cardiologist at Sault Area Hospital in Ontario, Canada, where he is deeply engaged in delivering high-level patient care, mentoring trainees, and advancing imaging-based diagnostic excellence. Dr. Abazid’s professional journey reflects a progressive expansion of knowledge across multiple cardiology subspecialties, supported by a rich portfolio of prestigious board certifications, including cardiovascular CT, nuclear cardiology, echocardiography, and certifications from renowned institutions in internal medicine and cardiovascular diseases. His training includes high-level fellowships in echocardiography, cardiovascular CT, and nuclear cardiology, complemented by hybrid imaging training that strengthened his multidisciplinary approach to cardiac diagnostics. Throughout his career, he has practiced in several leading medical centers, holding roles such as consultant cardiologist, specialist, senior registrar, and fellow in cardiovascular medicine, which allowed him to cultivate mastery across inpatient care, emergency cardiac assessment, outpatient management, and complex imaging modalities. Dr. Abazid is well known for his proficiency in echocardiography, including transthoracic, transesophageal, three-dimensional and intraoperative imaging, as well as stress testing and structural heart assessments. His expertise extends to cardiovascular CT for coronary assessment, congenital heart evaluation, aortic imaging, TAVI planning, prosthetic valve analysis, and calcium scoring using advanced imaging platforms. Additionally, he is experienced in nuclear cardiology, including SPECT, PET, viability assessment, amyloid imaging, sarcoidosis evaluation, and various stress testing protocols. Dr. Abazid has held significant administrative and leadership roles, including chairing the cardiac CT unit and the cardiac outpatient department, while also serving on ethics committees and leading scientific abstract committees within major cardiology organizations. As an active member of international professional societies and a contributor to authoritative educational modules, he continues to influence the evolution of cardiovascular imaging practice worldwide. Driven by academic excellence, clinical precision, and a passion for innovation, Dr. Abazid remains a respected figure in modern cardiology, dedicated to advancing patient outcomes and shaping the next generation of cardiovascular specialists.

Profile: Google Scholar

Featured Publications

Stocker, T. J., Deseive, S., Leipsic, J., Hadamitzky, M., Chen, M. Y., Rubinshtein, R., … Abazid, R.
Reduction in radiation exposure in cardiovascular computed tomography imaging: Results from the PROspective multicenter registry on radiaTion dose estimates of cardiac CT. European Heart Journal, 39(41), 3715–3723.

Einstein, A. J., Pascual, T. N. B., Mercuri, M., Karthikeyan, G., Vitola, J. V., … Abazid, R.
Current worldwide nuclear cardiology practices and radiation exposure: Results from the 65-country IAEA Nuclear Cardiology Protocols Cross-Sectional Study (INCAPS). European Heart Journal, 36(26), 1689–1696.

Ewid, M., Sherif, H., Allihimy, A. S., Alharbi, S. A., Aldrewesh, D. A., Alkuraydis, S. A., … Abazid, R.
AST/ALT ratio predicts the functional severity of chronic heart failure with reduced left ventricular ejection fraction. BMC Research Notes, 13(1), 178.

Abohamr, S. I., Abazid, R. M., Aldossari, M. A., Amer, H. A., Badhawi, O. S., … Jadaan, M. M.
Clinical characteristics and in-hospital mortality of COVID-19 adult patients in Saudi Arabia. Saudi Medical Journal, 41(11), 1217.

Abazid, R. M., Khalaf, H. H., Sakr, H. I., Altorbak, N. A., Alenzi, H. S., Awad, Z. M., … AlMubarak, N.
Effects of Ramadan fasting on the symptoms of chronic heart failure. Saudi Medical Journal, 39(4), 395–401.

Mercuri, M., Pascual, T. N. B., Mahmarian, J. J., Shaw, L. J., Dondi, M., Paez, D., … Abazid, R.
Estimating the reduction in radiation burden from nuclear cardiology through use of stress-only imaging in the United States and worldwide. JAMA Internal Medicine, 176(2), 269–273.

Rosario Megna | Clinical Trials | Research Excellence Award

Published on by Top Pharmaceutical

Dr. Rosario Megna | Clinical Trials | Research Excellence Award

National Research Council  | Italy

Dr. Rosario Megna is an accomplished physicist whose career spans high-energy physics, biomedical research, and advanced clinical imaging. He holds both a Master’s Degree and a Ph.D. in Physics, earned from two of Italy’s leading academic institutions, the University of Naples “Federico II” and the University of Bari. His academic foundations were built within the dynamic field of astroparticle physics, where he explored high-energy cosmic sources, matter-radiation interactions, Monte Carlo simulations, data acquisition systems, and advanced data analysis methodologies. During this early phase of his career, he contributed to several major international scientific collaborations, including ARGO-YBJ, NEMO, ANTARES, and KM3Net, and authored multiple research articles and conference contributions that advanced the understanding of fundamental astrophysical phenomena.Following his doctoral training, Dr. Megna expanded his research trajectory into the biomedical sciences through postdoctoral positions at the University of Bari and the National Institute for Nuclear Physics. Within this multidisciplinary environment, he applied physical principles to medical challenges, specializing in biomedical data management, computational analysis, and medical imaging. As part of the MAGIC-5 collaboration, he played a key role in developing a computer-aided detection system designed for the early diagnosis of lung cancer using computed tomography. This work allowed him to deepen his expertise in CT imaging, DICOM data acquisition, and pattern-recognition techniques tailored for clinical decision support.Dr. Megna later joined the National Research Council of Italy, where his contributions progressed from data storage and analysis for clinical and preclinical studies to broader responsibilities in statistics, database systems, biomedical signal processing, and modeling. As his role evolved into that of a research technologist and, subsequently, a senior research technologist, his research interests expanded to advanced statistics, machine-learning algorithms, risk assessment, and nuclear-medicine–based imaging techniques. His recent work focuses on clinical imaging for oncology and the optimization of radiotherapy approaches, integrating physics-driven innovation with real-world healthcare needs.Throughout his career, Dr. Rosario Megna has authored or coauthored more than fifty scientific publications and conference presentations, reflecting his sustained commitment to scientific advancement, interdisciplinary collaboration, and the translation of physics-based methodologies into impactful biomedical and clinical applications.

Profile: Orcid

Featured Publications

Gargiulo, S., Albanese, S., Megna, R., Gramanzini, M., Marsella, G., & Vecchiarelli, L. (2025). Veterinary medical care in rodent models of stroke: Pitfalls and refinements to balance quality of science and animal welfare. Neuroscience.

External validation of a predictive model for post‑treatment persistent disease by ¹³¹I whole‑body scintigraphy in patients with differentiated thyroid cancer. (2025). Journal not specified.

Cardiovascular risk factors and development of nomograms in an Italian cohort of patients with suspected coronary artery disease undergoing SPECT or PET stress myocardial perfusion imaging. (2024). Frontiers in Nuclear Medicine.

Megna, R. (2023). Evolution of the COVID‑19 pandemic in Italy at the national and regional levels from February 2020 to March 2022. AIMS Medical Science.

Petretta, M., Megna, R., Assante, R., Zampella, E., Nappi, C., Gaudieri, V., Mannarino, T., Green, R., Cantoni, V., D’Antonio, A., et al. (2023). External validation and update of the J‑ACCESS model in an Italian cohort of patients undergoing stress myocardial perfusion imaging. Journal of Nuclear Cardiology.